ClinicalTrials.gg
CompletedNCT07907107Updated Oct 30, 2026

Cognitive Behavioral Therapy for Self-Efficacy, Sleep Quality, and Fatigue After Stroke

An interventional study of cognitive behavioral therapy and Usual Care Group in Stroke, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Mansoura University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2026, registered Oct 2026).
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
60 Years and older
Sex
All
01

Study summary

Stroke is a major cause of long-term disability among older adults and may negatively affect self-efficacy, sleep quality, and fatigue. This study aims to evaluate the effect of a Cognitive Behavioral Therapy (CBT) program on self-efficacy, sleep quality, and fatigue in older adults after stroke. A total of 90 geriatric patients will be allocated to two groups: a study group receiving CBT in addition to usual care and a control group receiving usual care only. The CBT program will consist of seven modules delivered over eight individual sessions. Outcomes will be assessed at baseline and at one and two months after completion of the intervention using the Stroke Self-Efficacy Questionnaire, Pittsburgh Sleep Quality Index, and Fatigue Severity Scale. The findings are expected to provide evidence regarding the potential benefits of CBT in improving recovery-related outcomes and quality of life among older adults after stroke.

Read the detailed description

Phase I: Preparatory phase:

This phase included a review of literature, developing the study tools as well as testing the content validity and reliability of the study tools.

1. Administrative:

- Ethical approval will be obtained from the Research Ethics Committee of the Faculty of Nursing, Mansoura University.

  • Permission to conduct the study will be obtained from the responsible authorities of the study setting after explaining the aim and procedure of the study.

    2. Review of literature:

  • This will include a review of the past and current related literature and studies, using available books, periodicals, magazines and articles to become aware of the various aspects of the research problem.

    3. Developing the study tools and Cognitive Behavioral Therapy (CBT) program:

  • Tool I: A Structured Interview Schedule will be developed by the researcher. Tool II: Stroke Self-Efficacy Questionnaire, Tool III: The Pittsburgh Sleep Quality Index (PSQI), and Tool IV: Fatigue Severity Scale (FSS) will be used in this study.
  • The CBT program will include seven modules delivered across eight sessions, addressing maladaptive beliefs and behaviors that perpetuate sleep and fatigue symptoms. The program will also contain adaptations for common cognitive impairments after stroke, including a structured session format, concrete concepts, regular repetition, explicit discussion of how to use reminders for homework, written handouts, and additional support from therapists to help patients identify unhelpful thought patterns or behaviors.
  • The training will be performed once every week, including an educational session and a practical session, depending on geriatric patients' adherence and level of understanding.

    4. Validity of the study tools:

  • Content validity of the study tools will be assessed and revised by a panel of five experts in the field of Gerontological nursing. The tools will be revised for clarity, content, sequence of items, and relevance of the content to measure the variables they are intended to measure. Suggestions of the jury members will be followed.

Phase II: The exploratory phase:

It will include a pilot study and fieldwork.

Pilot study:

- A pilot study will be carried out on 10% of the total sample size (n = 9) to demonstrate the feasibility and applicability of the tools and to estimate the time needed for data collection. Geriatric patients who will be included in the pilot study will be excluded from the study sample.

Fieldwork:

Data collection period

- The researcher will start by introducing herself to the geriatric patients and giving them a brief idea about the aim and the nature of the study.

- The framework of the study will be carried out through four stages as follows:

  1. Assessment phase:

    Using all study tools, an initial assessment will be done to ensure that all geriatric patients are screened to confirm that they meet the inclusion criteria and are free from the exclusion criteria.

  2. Planning phase:

    - Geriatric patients will be divided into the study group (n = 45) and the control group (n = 45) by the researcher using the block randomization method (divided into block A and block B). In this way, the same number of geriatric patients in the study group and in the control group will be ensured. Geriatric patients in the study group will receive the CBT intervention, which will be delivered according to a standardized treatment manual comprising seven modules addressing fatigue and sleep over eight individual therapy sessions. The intervention will encompass the core CBT principles of psychoeducation, behavioral activation, behavioral experiments, cognitive restructuring, problem solving, and relapse prevention.

  3. Implementation phase:

    Each geriatric patient will be interviewed to collect baseline data using the study tools, and each geriatric patient in the study group will be given an educational session before starting the training sessions.

  4. Evaluation phase:

Outcomes will be evaluated one month and two months post-intervention.

02

Conditions studied

  • Stroke

Keywords

  • Cognitive Behavioral Therapy
  • Self-Efficacy
  • Sleep Quality
  • Fatigue
  • Post-Stroke
  • Geriatric Patients
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 90 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults aged 60 years or above, of both genders.
  • Available at the time of data collection.
  • Willing to participate in the study voluntarily.
  • Recent diagnosis of stroke.

Exclusion criteria

Exclusion Criteria:

  • Comorbid neurological disorders, such as seizures.
  • Scheduled surgery during the period of data collection.
  • Currently undergoing a psychological treatment program.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    study group have Cognitive Behavioral Therapy Program

    study group: involves patients who will receive cognitive behavioral therapy - program which include 7 modules delivering across 8 sessions, addressing maladaptive beliefs and behaviors perpetuating sleep and fatigue symptoms. Also, this program will contain adaptations for common cognitive impairments after stroke, by using session structure, concrete concepts, regular repetition, explicit discussion as to how homework use of reminders, written handouts, and additional support from therapists to identify unhelpful thought patterns or behaviors , training performed once every week including educational session and practical session depending on geriatric patient adherence and their level of understanding.

    Behavioral: cognitive behavioral therapy

  • Active comparator
    Control group: Usual Care Group

    Participants continued to receive usual post-stroke care as provided by the clinic, without CBT e.g., routine follow-up, medication management, supportive counseling.

    Other: Usual Care Group

Interventions

  • Behavioralcognitive behavioral therapy

    Cognitive behavioral therapy program will include 7 modules delivering across 8 sessions, addressing maladaptive beliefs and behaviors perpetuating sleep and fatigue symptoms. Also, this program will contain adaptations for common cognitive impairments after stroke, by using session structure, concrete concepts, regular repetition, explicit discussion as to how homework use of reminders, written handouts, and additional support from therapists to identify unhelpful thought patterns or behaviors

  • OtherUsual Care Group

    Participants continue to receive usual post-stroke care as provided by the clinic (e.g., routine follow-up, medication management, supportive counseling), without the cognitive behavioral therapy program.

06

What researchers measure

Primary outcomes

  1. Stroke Self Efficacy Questionnaire

    The Stroke Self-Efficacy Questionnaire was developed to measure self-efficacy after stroke. It was translated into Arabic and validated, and it has been shown to be reliable. Its reliability was tested using test-retest reliability with Spearman's correlation coefficient (r = 0.84). It consists of 13 statements divided into two domains: activity (items 1-8) and self-management (items 9-13). Responses are rated on a 4-point Likert scale: 0 = not at all confident, 1 = slightly confident, 2 = moderately confident, and 3 = very confident. Subscale scores are obtained by summing the responses. The possible range is 0-24 for the activity domain, 0-15 for the self-management domain, and 0-39 for the total perceived self-efficacy score. A higher score indicates higher self-efficacy.

    Time frame: Baseline, 1 month and 2 months after completion of the intervention

  2. The Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index (PSQI) is an effective instrument used to measure the quality and patterns of sleep in older adults. It was translated into Arabic and validated, and it has been shown to be reliable. Its reliability was tested using test-retest reliability with Spearman's correlation coefficient (r = 0.83). It differentiates poor from good sleep by measuring seven domains: subjective sleep quality, sleep latency (i.e., how long it takes to fall asleep), sleep duration, habitual sleep efficiency (i.e., the percentage of time in bed that one is asleep), sleep disturbances, use of sleeping medication, and daytime dysfunction. The patient self-rates each of these seven areas of sleep. Answers are scored on a 0-3 point Likert scale, where 3 reflects the negative extreme. The component scores are summed to produce a global score (range 0-21); higher scores indicate worse sleep quality. A total score of 5 or greater indicates poor sleep quality.

    Time frame: Baseline, 1 month and 2 months after completion of the intervention

Secondary outcomes

  1. Fatigue Severity Scale

    The Fatigue Severity Scale (FSS) was originally developed to assess the severity of fatigue and its effect on a person's activities and lifestyle in patients with several types of disorders. It was translated into Arabic and validated. Its reliability was evaluated using Cronbach's alpha (α = 0.902). The self-report scale includes nine statements concerning fatigue, its intensity, and how it affects specific activities. Answers are rated on a seven-point Likert scale, where 1 denotes strong disagreement and 7 denotes strong agreement. Thus, the lowest possible total score is 9 and the highest is 63. Scoring interpretation: the mean of all item scores is calculated, with a possible range of 1 to 7. A cutoff score of 4 or higher suggests problematic fatigue, whereas a score of 5 or higher signifies severe fatigue.

    Time frame: Baseline, 1 month and 2 months after completion of the intervention

07

Study locations

1 site
  • Mansoura University Hospital
    Al Mansurah, Dakahlia Governorate 35516, Egypt
08

References and documents

Publications

  • Chen W, Jiang T, Huang H, Zeng J. Post-stroke fatigue: a review of development, prevalence, predisposing factors, measurements, and treatments. Front Neurol. 2023 Dec 21;14:1298915. doi: 10.3389/fneur.2023.1298915. eCollection 2023. PubMed 38187145 ↗
  • Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, F Grupper M, Rautalin I. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025 Feb;20(2):132-144. doi: 10.1177/17474930241308142. Epub 2025 Jan 3. PubMed 39635884 ↗
  • Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3. doi: 10.1001/archneur.1989.00520460115022. PubMed 2803071 ↗
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. PubMed 2748771 ↗
  • Jones F, Partridge C, Reid F. The Stroke Self-Efficacy Questionnaire: measuring individual confidence in functional performance after stroke. J Clin Nurs. 2008 Apr;17(7B):244-52. doi: 10.1111/j.1365-2702.2008.02333.x. PubMed 18578800 ↗
  • Ahrens J, Shao R, Blackport D, Macaluso S, Viana R, Teasell R, Mehta S. Cognitive -behavioral therapy for managing depressive and anxiety symptoms after stroke: a systematic review and meta-analysis. Top Stroke Rehabil. 2023 May;30(4):368-383. doi: 10.1080/10749357.2022.2049505. Epub 2022 Mar 30. PubMed 35352629 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers to protect participants' privacy and confidentiality. Only aggregated study results may be reported in publications.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07907107
Responsible party
Azza Mohamed Ibrahim Shabana (Assistant lecturer of Gerontological Nursing, Mansoura University) — Principal investigator
First posted
Oct 30, 2026
Start date
Mar 3, 2026
Primary completion
Jul 27, 2026
Completion
Sep 29, 2026
Last update
Oct 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion